Rare alpha-1-antitrypsin variants: are they really so rare?
Alpha-1-antitrypsin (α1-AT) deficiency is mainly evaluated in the diagnostic process of chronic obstructive pulmonary disease (COPD). Around 95% of individuals with severe α1-AT deficiency carry the PI*ZZ genotype. Little is known about the epidemiology of the remaining deficient α1-AT variants, whi...
Main Authors: | Francisco Rodriguez-Frias, Marc Miravitlles, Rafael Vidal, Silvia Camos, Rosendo Jardi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-04-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465811434320 |
Similar Items
-
Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach
by: Belmonte I, et al.
Published: (2016-10-01) -
New variants of alpha-1-antitrypsin: structural simulations and clinical expression
by: Angel Gonzalez, et al.
Published: (2022-12-01) -
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01) -
Distribution of alpha1 antitrypsin rare alleles in six countries: Results from the Progenika diagnostic network
by: José Luis Lopez-Campos, et al.
Published: (2023-06-01) -
Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency
by: Timm Greulich, et al.
Published: (2018-08-01)